Table 2.

Effect of DECPR on the incidence of aberrant crypt categories (one, two, three, or four or more crypts) of the colons separated from the treated rats

Group	Number of crypts per ACF				Total	Inhibition (%)
	One crypt	Two crypts	Three crypts	Four or more crypts
A	0	0	0	0	0	N/A
B	46±1.22	47±1.89	55±1.98	34±1.40	182±6.47	N/A
C	19±1.03*	24±1.28*	22±2.62*	15±1.20*	80±6.13*	56.04
D	14±2.08*	19±1.79*	15±1.24*	9±0.67*	57±5.78*	68.68
E	14±0.50*	14±1.39*	11±1.22*	8±0.58*	47±3.69*	74.17

Notes: The five groups of rats were A: normal control; B: cancer control; C: low dose of DECPR; D: high dose of DECPR; and E: treatment control. Data are shown as mean ± standard error of the mean (n=6). Values are statistically significant at

^*P<0.05.

Abbreviations: ACF, aberrant crypt focus; DECPR, dichloromethane extract of Curcuma purpurascens rhizome; N/A, not applicable.